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PENGOPTIMUMAN IN SILICO ANTIBODI DOMAIN TERHADAP HSP16.3 
DARIPADA MYCOBACTERIUM TUBERCULOSIS 
 
 
ABSTRAK 
 
 Protein renjatan haba 16.3 (HSP16.3) daripada Mycobacterium tuberculosis 
(Mtb) adalah kritikal bagi kewujudannya semasa jangkitan pendam pada manusia, 
justeru menjadi sasaran menarik untuk strategi diagnostik dan terapeutik. Model 
struktur ramalan HSP16.3 didokkan terhadap prob hidrofobik HSP, iaitu 4,4′-
dianilino-1,1′-binaphthyl-5,5′-disulfonic acid (bisANS) dan pada model perbandingan 
HSP16.3-khusus antibodi domain tunggal (sdAbs), klon E3 dan F1. Interaksi 
pengikatan tersebut dijelaskan lebih lanjut dengan pengiraan tenaga bebas. Interaksi 
bukan-kutub telah dikenalpasti sebagai kuasa utama untuk peyatuan antigen-antibodi. 
Dengan menggunakan penguraian tenaga bebas setiap residu dan pengiraan 
pengimbasan alanina, residu-residu kelompok hangat pada E3 (Y391) dan F1 (M394, 
Y396, R397 dan M398) telah dikenalpasti. Residu-residu tersebut ditaklukkan kepada 
mutagenesis in silico berdasarkan cadangan oleh pelayan web mCSM-AB. Kesan 
mutasi pada kompleks HSP16.3-dAb dianalisis dengan simulasi dinamik molekul, 
pengiraan tenaga bebas dan penguraian tenaga bebas setiap residu. Kompleks 
HSP16.3-E3Y391W diramal mempamerkan peningkatan sebanyak 69% dalam tenaga 
bebas pengikatan berbanding dengan E3 jenis liar. Sebaliknya, tahap peningkatan 
tertinggi bagi F1 jenis liar adalah HSP16.3-F1R397N (44%), diikuti oleh HSP16.3-
F1M398Y (33%), HSP16.3-F1M394E (29%) dan akhir sekali HSP16.3-F1M398W (6%). 
Kesimpulannya, dAbs (E3 dan F1) berjaya dioptimumkan terhadap HSP16.3 pada 
tahap in silico. Penemuan ini boleh digunakan sebagai garis panduan bagi reka bentuk 
dAbs yang lebih tinggi affiniti terhadap HSP16.3 pada tahap in vitro pada masa depan.  
xiv 
 
IN SILICO OPTIMISATION OF DOMAIN ANTIBODIES AGAINST HSP16.3 
FROM MYCOBACTERIUM TUBERCULOSIS 
 
 
ABSTRACT 
 
 Heat shock protein 16.3 (HSP16.3) from Mycobacterium tuberculosis (Mtb) is 
critical for its survival during latent infection in human, thus making it an attractive 
target for developing diagnostic and therapeutic strategies. The predicted structure of 
HSP16.3 was docked against a known HSP hydrophobic probe, namely 4,4′-dianilino-
1,1′-binaphthyl-5,5′-disulfonic acid (bisANS) and to the comparative models of 
HSP16.3 specific single domain antibodies (sdAbs), clone E3 and F1. The binding 
interactions were further elucidated by free energy calculations. The non-polar 
interactions were identified as the main force for antigen-antibody association. By 
using per-residue free energy decomposition and computational alanine scanning, the 
hot spot residues in E3 (Y391) and F1 (M394, Y396, R397 and M398) had been 
identified. These residues were subjected to in silico mutagenesis based on suggestions 
by mCSM-AB webserver. The mutational effects on HSP16.3-dAb complex were 
analysed using molecular dynamics simulation, free energy calculations and per-
residue free energy decomposition. The HSP16.3-E3Y391W complex was predicted to 
exhibit up to 69% improvement in its binding free energy over the E3 wild type. On 
the other hand, the highest improvement in F1 wild type was HSP16.3-F1R397N (44%), 
followed by HSP16.3-F1M398Y (33%), HSP16.3-F1M394E (29%) and lastly HSP16.3-
F1M398W (6%). Thus, it can be concluded that the dAbs (E3 and F1) have been 
successfully optimised against HSP16.3 at in silico level. These findings could serve 
as guidelines for design of higher affinity dAbs against HSP16.3 at in vitro level in the 
future.
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Problem Statement 
Mycobacterium tuberculosis (Mtb) survives long-term dormancy due to cell 
wall thickening and upregulation of heat shock protein 16.3 (HSP16.3) which 
stabilises its cell structures (Cunningham & Spreadbury, 1998). The HSP is 
predominantly found in latent tuberculosis infection (LTBI) individuals before it 
develops or reactivates into active stage. By treating LTBI, it minimises the risk of 
progression to active tuberculosis (TB). Therefore, detection of LTBI in time plays a 
crucial role in global effort to combat TB epidemic. In this study, the domain 
antibodies (dAbs) provided by collaborator had exhibited good binding affinity 
towards HSP16.3, major antigen detected in LTBI (Bahara et al., 2016). Thus, these 
dAbs could be promising candidates as diagnostic biomarkers. To achieve good 
diagnostic accuracy, binding affinity of dAbs against HSP16.3 can be further 
optimised. However, antibody optimisation via laboratory approach is expensive and 
time-consuming. Therefore, in silico approach offers an alternative method to enhance 
the binding affinity of dAbs against HSP16.3. 
 
1.2 Background of Study 
 TB prevails as one of the most ominous global health threat. During the 18th 
and 19th centuries, TB emerged as an escalating epidemic of communicable disease 
(Daniel, 2006). The lack of knowledge about disease containment has left the world 
appalled at confirmed diagnostic evidence of the deadly TB infection in those days. 
2 
 
Despite advances in current medical technology, this age-old disease has ailed a 
staggering number of 10.4 million people and claimed at least 1.4 million lives in year 
2015, according to World Health Organisation report (WHO, 2016). Thus, one should 
not make light of the threats posed by TB. 
WHO estimated that 5-15% of people infected with Mtb stand a risk of 
developing TB disease later in life (WHO, 2016). In line with End TB Strategy, LTBI 
treatment coverage is one of the indicators used by WHO to monitor implementation 
of the strategy. Examples of high-risk groups for LTBI include children aged under 
five years with close contact with culture-positive pulmonary TB patients, HIV-
positive patients and citizens in high TB burden countries.  
As a means to prevent and contain the infectious disease, it is a priority to 
characterise mycobacterial antigens for better understanding of the molecular 
mechanism of pathogen to stay in dormant stage and its pathogenesis. A 16 kDa alpha 
crystalline-like small heat shock protein (sHSP) has been identified to be latency 
associated antigen predominantly expressed by Mtb (Yuan et al., 1996). Several 
studies have directed HSP16.3 as a potential diagnostic marker (Davidow et al., 2005; 
Kashyap et al., 2011; Rabahi et al., 2007; Shekhawat et al., 2016; Silva et al., 2014; 
Zhang et al., 2015), and shared principal findings whereby the 16 kDa antigen has 
elevated levels in latent TB subjects.  
 Antibodies targeting major antigen can contribute in the advancement of 
research, diagnosis and possible therapeutics of TB. Instead of using conventional 
antibodies, single-domain antibodies (sdAbs) were selected in order to study their 
interactions with HSP16.3 in this research. Other than being smaller in size, sdAbs 
possess high physical-chemical stability, good water solubility and better penetration 
in reaching target antigens (Eyer & Hruska, 2012). The dAbs have been reported to 
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have reasonable expression level, good solubility and capable of binding to HSP16.3 
at denaturing environment (Bahara et al., 2016). Therefore, further optimisations of 
these dAbs against HSP16.3 in this study could be useful for development in 
diagnostics and therapeutics. 
On the other hand, recent progress on in silico approach contributed to the 
exponential growth of computational modelling which in turn enables antibodies to be 
re-designed or optimised to portray better affinity or other favourable changes (Kuroda 
et al., 2012). This is due to in silico simulation can enable more directional mutations 
at complementarity determining regions (CDRs) to be studied at a relatively lower 
running cost. For example, an early study employed computational modelling to select 
favourable residues for random mutagenesis (Barderas et al., 2008). As a result, they 
obtained novel antibodies with 454-fold more enhanced binding affinities over the 
wild type (WT). 
 
1.3 Scope of Study 
The study started with the modelling of HSP16.3. The reliability of HSP16.3 
model was evaluated by analysing its interactions with 4,4′-dianilino-1,1′-binaphthyl-
5,5′-disulfonic acid (bisANS), a known hydrophobic ligand for sHSPs. Next, dAbs 
were modelled and docked to predicted epitopes on HSP16.3. Interactions established 
in docked complexes were investigated by molecular dynamics (MD) simulation and 
binding free energy calculations. Computational alanine scanning and per-residue 
binding free energy calculations were then performed on the dAbs. In silico 
mutagenesis was performed on the identified hot spot residues in dAbs. Successful 
dAb mutants with enhanced binding affinity against HSP16.3 were identified by 
improvement in their binding free energy compared to WT. 
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1.4 General Objective 
 The general objective in this study is to optimise the HSP16.3-specific dAbs 
for possible binding affinity improvement with HSP16.3 at computational level. 
 
1.5 Thesis Outline 
 Chapter one enlightens the current status of TB by providing background of 
study and addressing problems to be solved. It also included scope, general objective 
and outlined the thesis structure.  
 Chapter two covers the first stage of study which involved predicting the 
structure of HSP16.3 and exploring its interactions with bisANS. Specific objectives 
and introductory concepts of HSP16.3 structure and relevant computational 
approaches in structural biology were discussed too. Protocols used and research 
findings can be referred to methodology, results and discussion sections respectively. 
 Chapter three highlights on the second stage of study which focused on 
modelling of dAbs, docking of dAbs to HSP16.3, binding free energy calculations of 
docked complexes and assessment of point mutational effects in dAbs on their binding 
affinities against HSP16.3. An overview on antibody design and the successes of 
computer-aided antibody design were provided in introduction. Specific objectives can 
also be found. Detailed protocol and research outcomes can be found in methodology, 
results and discussion sections respectively.  
 Chapter four concludes the overall research findings, acknowledges limitations 
in this study and suggests directions for future research.   
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CHAPTER 2 
 
PREDICTING THE STRUCTURE OF HSP16.3 
 
2.1 Introduction 
2.1.1 Structural and Functional Studies of HSP16.3 
 In times of cellular stress, HSPs (as the stress proteins) are often upregulated 
as part of cellular defensive response. The vital role of HSPs in stress tolerance makes 
them highly conserved and ubiquitous across species. By distinguishing HSPs on the 
basis of molecular mass, it results in six major classes i.e. HSP100, HSP90, HSP70, 
HSP60, HSP40 and sHSPs (Bakthisaran et al., 2015). The present study focused on a 
sHSP, namely HSP16.3 (Verbon et al., 1992), a membrane protein which facilitated 
the persistence of Mtb (Cunningham & Spreadbury, 1998). 
 In general, sHSPs have molecular mass ranging from 12-43 kDa, that 
agglomerates into diversified oligomers consisting of 4-42 subunits (Schumann, 2006). 
The domain architecture of sHSP family constitutes of a highly conserved α-crystallin 
domain (ACD) that is placed between variable N-terminal and C-terminal regions, as 
discussed in a review (Hilton et al., 2013). The C-terminal region can be further 
divided into C-terminal tail, IXI motif and C-terminal extension. Acting as ATP-
independent chaperones, sHSPs bind denatured proteins to prevent unwanted 
aggregation (Jakob et al., 1993). It is postulated that these bound proteins are subjected 
to refolding, being degraded to smaller peptides or spontaneous release.  
The identified 16 kDa HSP16.3 is consistent with the known size range of 
sHSPs (Lee et al., 1992). The chaperone-like activity of HSP16.3 is evidenced from 
an early study whereby it had successfully inhibited thermal aggregation of citrate 
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synthase at elevated temperature (Chang et al., 1996). In addition, novel function of 
HSP16.3 has been unveiled in a recent discovery that reported its ability to prevent 
thermal inactivation of enzymes (Panda et al., 2017).  
  The critical role of the N-terminal and C-terminal region of HSP16.3 has been 
extensively highlighted in an early study (Fu et al., 2005). A few observations had 
been noticed. The absence of first 35 N-terminal residues was found to dissociate the 
oligomeric assembly, abolished its substrate binding capability and chaperoning 
activity. Apart from that, removal of C-terminal extension (nine residues) could lead 
to oligomeric dissociation and enhanced its chaperoning activity. Moreover, varying 
C-terminal truncated forms of HSP16.3 exhibited different strengths of chaperone 
function (Panda et al., 2017). These results thus suggested the importance of C-
terminal extension in chaperone function, oligomerisation and its dynamics. 
Due to the diagnostic potential of HSP16.3 (Davidow et al., 2005; Kashyap et 
al., 2011; Rabahi et al., 2007; Shekhawat et al., 2016; Silva et al., 2014; Zhang et al., 
2015), the research community is intrigued to determine its protein structure. Protein 
structure determination often plays a pivotal role as it holds the key to understanding 
the protein functions better. By unearthing new pieces of structural information, it 
would be helpful to gain further insights into the immunodominant antigen of Mtb.  
Nevertheless, elucidating the macromolecular assembly of HSP16.3 is an 
exceptionally challenging task. Previously, the oligomeric form of HSP16.3 was 
proposed as a nonamer that formed by trimers (Abulimiti et al., 2003; Chang et al., 
1996; Gu et al., 2002). The early findings were then contradicted by later research. 
There is conclusive evidence that showed HSP16.3 as a dodecamer built from six 
homodimers arranged in a tetrahedral assembly (Kennaway et al., 2005). The atomic 
coordinates of a wheat HSP16.9 dimer was fitted to the electron microscopy (EM) 
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density map to construct the HSP16.3 dodecameric assembly. Although it offered new 
perspectives on molecular architecture of HSP16.3, there is missing structural 
information on N-terminal region and C-terminal tail. Due to observed sequence 
divergence between HSP16.3 and template in the above-mentioned regions, they were 
not included in the 3D reconstruction study. Considering the significance of the N-
terminal region, in silico approaches were thus employed to predict the full structure 
of HSP16.3 in this study. The following sections introduce and briefly discuss about 
relevant computational approaches in predicting and refining theoretical protein 
structure. 
 
2.1.2 Employing in Silico Approaches in Structural Biology 
 As the key determinant of its 3D structure, protein sequence provides clues 
about its protein functionality. By obtaining structural information of the target protein, 
structural biologists might be able to infer its protein functions. Therefore, numerous 
studies are dedicated towards determining protein structures to annotate their unknown 
functions (Kennaway et al., 2005; van Montfort et al., 2001).  
X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy 
are commonly employed in structural studies of proteins. However, conventional 
experimental methods often face inevitable hurdles such as lengthy time, laborious 
process and high experimental cost. Furthermore, novel protein sequences are being 
rapidly discovered at a pace that far exceeds the amount of known structures. To 
address the knowledge gap, in silico approaches offer an attractive alternative for 
protein structure prediction, thus serve as an essential complement to existing 
experimental methods.  
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2.1.3 Protein Structure Prediction Using Comparative Modelling 
Computational protein structure prediction is classified into two major 
approaches, namely template-based modelling (TBM) and ab initio modelling. The 
TBM approach is based on the principle that higher possibility of predicting the model 
folding correctly when its sequence identity is above 30% (Sánchez and Sali, 1998). 
Therefore, it is possible to predict structure of a given target sequence by aligning it to 
an experimentally solved homologous protein structure. This is commonly known as 
comparative modelling. However, it is later discovered that distantly related protein 
sequences also share similar structural patterns (Bowie et al., 1991), thus contributed 
to the concept of threading. In threading, target sequence is aligned to known protein 
structures to predict its tertiary folds by matching residue environments. On the other 
hand, ab initio modelling predicts native-like conformations for target sequence in the 
absence of known structure homologues (Lee et al., 2009). The most 
thermodynamically stable model is selected by identifying the conformation that is 
close to the global free-energy minimum from the pool of structural decoys.   
Since comparative modelling is a well-established approach, various 
comparative protein modelling tools have been developed and made available. Some 
examples of the popular modelling tools include SWISS-MODEL (Arnold et al., 2006) 
and MODELLER (Šali & Blundell, 1993). Regardless of the choice of tools, 
conventional comparative modelling protocol usually consists of a few sequential 
steps. It begins searching for suitable templates, aligning target sequence to selected 
templates, building the model and lastly evaluating the reliability of the built model. 
These sequential steps will be further elaborated using MODELLER as the modelling 
tool.  
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As a preliminary step, template selection is non-trivial in comparative 
modelling. There are several things to consider before deciding on the most suitable 
template for modelling. Other than prioritising sequence similarity, quality of the 
potential template is equally important (Fiser, 2010). Structural divergence and poor 
template quality could usually affect the modelling accuracy. A minimum of 30% 
template sequence identity and a good template-sequence alignment, are likely to build 
a reliable model that overlaps the actual structure about 75-90% (Forrest et al., 2006; 
Sánchez & Sali, 1998). In the case of multiple potential templates that share high 
sequence similarity with target sequence, the template determined at better resolution 
shall be selected (Sánchez & Šali, 2000). To further improve modelling accuracy, 
multiple templates are commonly used as they can provide adequate structural 
information for matching protein regions (Webb & Sali, 2014).  
 After identifying ideal template, the next step is sequence alignment. Likewise, 
caution shall be exercised while performing an alignment. Misalignment can introduce 
unrecoverable errors during modelling. Thus, numerous alignment algorithms have 
been devised to optimise the alignment accuracy and improve the protein structure 
prediction. For instance, variable gap penalty (VGP) algorithm in MODELLER 
(Madhusudhan et al., 2006). The algorithm is based on a global dynamic programming 
algorithm, alternatively known as the Needleman-Wunsch algorithm after the names 
of developers (Needleman & Wunsch, 1970). Basically, the Needleman-Wunsch 
algorithm describes how to find the best global pairwise alignment that holds the 
optimal alignment score. The use of a score matrix enables scores to be assigned for 
observed amino acid substitutions during alignment. Next, a traceback matrix is 
employed to keep track of the maximum score value and to deduce the best alignment 
along the traceback path. The VGP algorithm distinguishes itself from conventional 
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alignment approaches by including structural information from selected template 
(Madhusudhan et al., 2006). To improve alignment accuracy, gap penalties are given 
when gaps are placed within secondary structure elements, straight backbone segments 
that are solvent inaccessible and residues that are not within close spatial proximity.  
 The theoretical model can now be built using the sequence-template alignment. 
Guided by spatial restraints derived from alignment, MODELLER can predict the most 
probable conformation of target sequence (Eswar et al., 2007; Šali & Blundell, 1993). 
The spatial information can be retrieved from homology-derived restraints and 
stereochemical restraints. The homology-derived restraints regarding distances and 
dihedral angles in target sequence are inferred from its structural alignment with 
homologous proteins. On the other hand, the stereochemical restraints (bond length 
and bond angle preferences) are retrieved from the Chemistry at Harvard 
Macromolecular Mechanics force field (CHARMM22) (MacKerell et al., 1998) and 
statistical data of dihedral angles and non-bonded atomic distances from databases of 
known protein structures. Optimisation of the built model is then performed using the 
variable target function method (VTFM) (Braun & Go, 1985) with conjugate gradients 
(CG), followed by molecular dynamics (MD) to minimise violations of the spatial 
restraints.  
 Upon completion of model building, it is necessary to evaluate the model 
quality. The Discrete Optimised Protein Energy (DOPE) is a scoring function 
implemented in MODELLER to rank and to discriminate the most native-like model 
among a pool of decoys (Shen & Sali, 2006). As an atomic distance-dependent 
statistical potential, DOPE is based on physical reference state that describes the finite 
and spherical shape of native proteins. Model with more negative DOPE score 
assigned can be considered well correlated to native-like model. Additionally, 
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evaluation of model accuracy can also be made using the GA341 method in 
MODELLER (John & Sali, 2003; Melo et al., 2002). The GA341 score is calculated 
by assessing structural compactness, combined statistical potential Z-score of model 
and sequence identity of the alignment used for modelling. The reliability of the model 
increases as the GA341 score close to 1.0.  
 For more robust examination on the stereochemistry of comparative model, a 
Ramachandran plot (Ramachandran et al., 1963) can be used to highlight potential 
errors in model regions that require further optimisation. There are many programs 
such as PROCHECK (Laskowski et al., 1993) and RAMPAGE (Lovell et al., 2003), 
that include Ramachandran plot analysis for model assessment. First described by 
Ramachandran (1963), the plot defines the range of allowed phi and psi dihedral angles 
in a protein that avoid steric collisions between atoms. It is generally accepted that a 
good model should have above 90% of its residues located in the most favoured 
regions (Laskowski et al., 1993). Other than that, the spatial properties of built models 
can be assessed using Verify3D (Bowie et al., 1991; Luthy et al., 1992) and ProSA-
web (Sippl, 1993; Wiederstein & Sippl, 2007). In Verify3D, the compatibility of the 
predicted model structure with its amino acid sequence is verified by its 3D profile. 
Therefore, a modelled segment with low profile score indicates an incorrect structure. 
On the other hand, ProSA calculates Z-score of protein model which indicates its 
overall quality and compares it with scores observed for known protein structures. 
Besides, regional model quality is examined by measuring energies as a function of 
amino acid sequence position. Regions with positive energy values hint at erroneous 
parts of the model.  
Although comparative modelling has made great strides in solving 3D 
structures of target proteins, there are certain limitations to overcome, such as template 
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identification and alignment accuracy. For these reasons, model assessment becomes 
an essential step as it ultimately determines the reliability of the comparative model to 
be used for addressing biological questions. The quality of a comparative model can 
always be improved by iterating the abovementioned modelling steps until satisfying 
result is achieved.  
 
2.1.4 Protein-Ligand Docking 
Molecular docking is crucial for elucidating interactions between biomolecules 
at the atomic level to understand the underlying fundamental biochemical processes. 
Docking studies that involve protein-ligand interactions and protein-protein 
interactions have garnered considerable research interest given their pharmaceutical 
and therapeutic significance. Furthermore, the computer-aided molecular docking 
offers an attractive alternative to determine binding modes and affinities in molecular 
recognition, in contrary to conventional experimental approaches which are laborious 
and costly (Huang & Zou, 2010). The subject of this section will be focusing on 
protein-ligand docking.  
Prior to docking, it is necessary to identify putative binding region in protein 
to increase docking efficiency (McConkey et al., 2002). The binding region can be 
identified from literatures or with the help of binding site prediction tools. This binding 
site information helps to narrow down the conformational sampling space and allows 
intensive conformational sampling of ligand on the predefined protein region. Finally, 
scoring function is used to discriminate near native docked pose from decoys. In short, 
the docking performance is closely associated with sampling or scoring.  
To tackle docking problem, a variety of docking tools and programs based on 
different algorithms have been developed. Although some of the newly released 
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docking programs proclaim to have better accuracy and speed, there are doubts on the 
validity of results and their performance (Wang et al., 2016). In contrary, traditional 
docking program such as AutoDock suite is well validated and its predictions are 
reliable. Besides that, the availability of its interactive graphical user interface 
simplifies the setup and docking analysis (Morris et al., 2008).  
AutoDock suite performs ligand sampling by implementing the stochastic 
search method. It generates an ensemble of ligand binding poses by randomly 
changing the translational and rotational position of ligand, together with its torsion 
angles (Forli et al., 2016). The method is based on genetic algorithm (GA), a popular 
class of evolutionary algorithm to guide the prediction of optimal ligand binding 
conformations (Huang & Zou, 2010). In GA, the global minimum energy 
conformation is searched using user defined rates of cross-over and random mutations. 
It works in similar manner as biological evolution; binding mode with lowest energy 
score is ultimately selected. Meanwhile, introduction of Lamarckian genetic algorithm 
(LGA), an improved version of traditional GA, performs search in local 
conformational space to identify local minima which will be passed on to its offspring 
(Morris et al., 1998).  
In AutoDock 4, a semiempirical free energy force field is implemented to rank 
docked decoys (Huey et al., 2007). Unlike its predecessor, the force field incorporates 
intramolecular energies in binding free energy estimation. This makes the scoring 
function for docking comparable to function for binding free energy prediction. Hence, 
it successfully solves the common problem encountered in empirical free energy force 
fields. There are two aspects evaluated for receptor-ligand binding: intramolecular 
energetics for both receptor and ligand in their apo and holo forms, intermolecular 
energetics of receptor-ligand complex. In addition, a novel charge-based desolvation 
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method with defined atom types and charges is incorporated as well.  
 To date, numerous molecular interactions have been successfully elucidated 
using docking approach. It has identified natural inhibitors against the primary targets 
for cervical cancer (Kumar et al., 2014), helped in developing pheromone trap for 
rodent pest management by evaluating binding affinity between pheromone 
compounds and its targeted carrier protein (Rajesh et al., 2016), studied  the 
interactions of new antifungal drugs against an essential enzyme in fungi (Saha et al., 
2012) and used in a wide range of applications.  
 
2.1.5 Molecular Dynamics (MD) 
MD simulation serves as a powerful in silico approach to study molecular 
motions as a function of time. The physical movement of particles in a system can be 
deduced by solving Newton’s second equation of motion (Leach, 2001). Thus, it 
generates a trajectory that describes time-dependent behaviour of particles.  
Numerous force field models have been developed to simulate different types 
of biomolecules. Basically, a force field is a mathematical expression that describes 
the dependence of the energy of a system on its particle coordinates (González, 2011). 
It can be represented by the following expression: 
𝑈 = ∑
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2
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The first four terms in expression describe bonded term contributions (bond stretching, 
angle bending, dihedral and improper torsions) to the total energy whereas the last two 
terms describe non-bonded terms, namely repulsive and van der Waals (vdW) 
interactions and Coulombic interactions. In simple terms, a force field provides 
(Eq. 2.1) 
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parameterisation for the energy surface of protein (Guvench & MacKerell, 2008). 
These force field parameters are derived from quantum mechanical calculations or 
experimental studies (Adcock & McCammon, 2006). Examples of some popular 
protein force field models are AMBER (Cornell et al., 1995), CHARMM (MacKerell 
et al., 1998) and GROMOS (Oostenbrink et al., 2004).   
In practice, a standard MD simulation is performed under isothermal-isobaric 
conditions (Nurisso et al., 2012). Prior simulation, an initial structure (experimentally 
determined or computationally predicted) is prepared by fixing structural errors such 
as missing atoms, assigning atom types and charges and adding solvent molecules. The 
system is simulated in the presence of explicit solvent. The computational cost is saved 
by applying periodic boundary conditions to minimise non-essential calculations of 
solvent degree of freedom (Wassenaar & Mark, 2006). Energy minimisation is then 
carried out to relax the initial structure. After heating up the system to the desired 
temperature, the system is equilibrated to achieve stability which is usually assessed 
in terms of energy, density, temperature and pressure. Next, the equilibrated system is 
subjected to production phase which collects structural and energetic data versus time. 
Finally, the sampled trajectories are analysed in terms of thermodynamic, structural 
and dynamical properties.  
The applicability of MD has been described for refining comparative models 
(Nurisso et al., 2012), its role in drug discovery (Durrant & McCammon, 2011) and 
protein design (Childers & Daggett, 2017). On top of that, it is also frequently used as 
complementary with docking method because it offers more realistic energy prediction 
of a bound complex than computational docking (Forli et al., 2016). Given the 
advancement in computing power, it is now possible to perform an all atom MD 
simulation involving larger system that consists millions of atoms on an extended time 
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scale up to millisecond. The development of theories and algorithms that mimic 
experimental conditions allow to perform realistic MD simulation (Adcock & 
McCammon, 2006). This enable MD to serve as a computational microscope that 
illustrates biochemical processes in atomic detail which is difficult to examine in 
experiment.  
 
2.1.6 Energetic Characterisation of Protein-Ligand Interaction Surface  
Binding free energy is main indicator for complex stability, which is central to 
all biomolecular binding events (Adcock & McCammon, 2006). Using MD, the 
binding conformations and corresponding binding free energies can be predicted for 
protein-ligand complexes.  
Molecular mechanics generalised Born and Poisson-Boltzmann surface area 
continuum solvation methods (MM-GBSA/PBSA) are commonly employed in free 
energy calculations of protein-ligand system. Alternatively, they are known as end-
point methods as binding free energy is computed using the bound and unbound states 
of system. Therefore, it is computationally less demanding. 
In general, the binding free energy for protein-ligand complex formation can 
be obtained as below (Pearlman, 2005): 
ΔGbind = G (protein-ligand complex) – G (protein) – G (ligand)     (Eq. 2.2) 
On the other hand, the binding free energy for each molecular system (protein, ligand 
and protein-ligand complex) can be expressed as summation over three components: 
ΔGbind = ΔEMM + ΔGsolv – TSsolute       (Eq. 2.3) 
In equation 2.3, ΔEMM is molecular mechanics energy in gas phase, ΔGsolv is solvation 
free energy and Ssolute is the solute entropy. The molecular mechanics term can be 
further decomposed to bonded and non-bonded energy whereas the solvation free 
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energy term can be further divided into polar contribution (electrostatic part from 
solvation model) and non-polar contribution (solvent-accessible surface area, also 
known as SASA). Due to high computational cost associated with solute entropy term 
estimation and its lack of conformational information, the term is often ignored in 
calculation (Genheden & Ryde, 2015). 
 The reliable performance of MM-GBSA/PBSA approaches and their ability to 
predict binding free energies comparable to experimental values have been reported 
previously (Genheden & Ryde, 2012; Rastelli et al., 2010). Despite the success of 
MM-GBSA/PBSA in predicting ligand binding affinities, there are certain underlying 
limitations. For example, questionable entropy contributions and data accuracy that 
heavily depended on conformational space sampled and parameters assigned (Weis et 
al., 2006). Nevertheless, both approaches are still appealing as they offer fast 
prediction of receptor-ligand binding thermodynamics at computational level.  
 
2.2 Specific Objectives 
i) To predict the three-dimensional (3D) structure of HSP16.3 
ii) To evaluate the predicted 3D structure of HSP16.3 
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2.3 Methodology 
 The following flow chart outlines the overall research design in predicting 
HSP16.3 structure (Figure 2.1): 
 
Figure 2.1 The overall methodology flowchart of HSP16.3 structure prediction 
 
2.3.1 Comparative Modelling of HSP16.3 
The target sequence of HSP16.3 (accession ID: P9WMK1) was retrieved from 
the UniProt Knowledgebase (UniProtKB) (The Uniprot Consortium, 2017). Prediction 
servers were used to perform preliminary sequence analysis by predicting its 
secondary structures (APSSP2 (Raghava, 2002), Jpred4 (Drozdetskiy et al., 2015), 
SSpro (Cheng, Randall, et al., 2005), PORTER (Pollastri & McLysaght, 2005), 
PredictProtein (Rost et al., 2004) and PSIPRED v3.3 (Buchan et al., 2013; Jones, 
1999)), disordered regions (DISpro (Cheng, Sweredoski, et al., 2005), IUPred 
(Dosztányi et al., 2005), Meta-Disorder (Kozlowski & Bujnicki, 2012), PONDR (Li 
et al., 1999; Romero et al., 2001), PrDOS (Ishida & Kinoshita, 2007) and RONN v3.2 
(Yang et al., 2005)) and functional sites (Consurf server (Ashkenazy et al., 2010; 
Berezin et al., 2004; Celniker et al., 2013)). Suitable candidate templates were 
identified by Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990) 
against Protein Data Bank (PDB) proteins (Berman et al., 2000), followed by aligning 
the target and template sequences using MODELLER 9.14 program (Šali & Blundell, 
Comparative modelling of HSP16.3
Docking of bisANS to HSP16.3 dimer
MD simulation of HSP16.3-bisANS complex
Free energy calculation and per-residue decomposition
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1993). During modelling, symmetry restraints were applied on the HSP16.3 
dodecamer to achieve symmetry on each chain. From the pool of comparative models, 
the best model which was defined as the model with the lowest DOPE score (Shen & 
Sali, 2006), was selected for further loop refinement. Lastly, the quality of the model 
was examined using model evaluation servers such as Verify3D (Bowie et al., 1991; 
Luthy et al., 1992), PROCHECK Ramachandran (Laskowski et al., 1993) and ProSA-
web (Sippl, 1993; Wiederstein & Sippl, 2007).  
 
2.3.2 Docking Simulation of bisANS to HSP16.3 Dimer 
An early study has shown that HSP16.3 exists in dimeric form after standard 
HSP isolation procedures (Srivastava et al., 2013). Therefore, docking simulation was 
performed on HSP16.3 dimer (chain A and B). To evaluate binding properties of 
HSP16.3 dimer, a known hydrophobic probe for HSP, bisANS was chosen for the task. 
The AutoDock 4.2.6 software (Morris et al., 2009) and its graphical front-end, 
AutoDockTools were used in docking simulation. The ligand coordinate file for 
bisANS was prepared using ChemDraw Professional 15.0. Next, Gasteiger charges 
were calculated and hydrogen atoms were added for both HSP16.3 dimer and bisANS. 
The HSP16.3 dimer was regarded as rigid entity whereas flexibility of bisANS was 
allowed up to seven torsional degrees of freedom. The grid size was defined as 126 × 
126 × 126 points, centered at -2.444, -0.152 and 13.965 with grid spacing of 0.375 Å. 
The docking search parameter chosen was Lamarckian genetic algorithm. The 
population size was set to 150; maximum number of energy evaluations at 2,500,000; 
maximum number of generations at 27,000. Default values were used for remaining 
parameters. A total of 1000 docking runs was performed. All conformations generated 
were clustered using root mean square deviation (RMSD) tolerance of 2.0 Å. 
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2.3.3 MD Simulation of HSP16.3-bisANS Complex 
MD simulation was performed with AMBER 12 (Case et al., 2012) to evaluate 
stability of the docked HSP16.3-bisANS complex and to study its dynamics. Since the 
system involved a protein-ligand complex, the geometry of ligand (bisANS) was first 
optimised using Antechamber tool (Wang et al., 2006). The partial charges of bisANS 
were assigned using AMC-B11 charge model (Jakalian et al., 2000; Jakalian et al., 
2002) and ligand parameters were defined by general AMBER force field (GAFF) 
which is specific for small organic molecules (Wang et al., 2004). Next, the system 
was set up by preparing complex topology and coordinates files required for simulation. 
The AMBER force field FF14SB (Maier et al., 2015), an significant improvement over 
its predecessor in terms of optimised dihedral parameters for protein backbone and 
side chains, was applied along with GAFF. Counterions (14 sodium ions) were added 
to neutralise the system. For newer force fields such as FF14SB, the ion parameters 
for TIP3P water (Jorgensen et al., 1983) were required to be sourced. After loading 
necessary ion parameters, a truncated octahedral TIP3P water box of 12.0 Å was added 
to solvate the docked complex. The total number of atoms in system were 106, 909. 
Prior to MD, the solvated complex was subjected to two rounds of minimisation. 
During the first minimisation stage, 1000 minimisation cycles were performed with 
positional restraints (force constant of 100 kcal/mol/Å2) to fix the solvated complex at 
reference position. The use of restraints could be useful to prevent structural distortions 
during beginning of energy minimisation (Struthers et. al., as cited in Greer, 1991). 
The subsequent minimisation stage which involved 2000 minimisation cycles was 
carried out without positional restraints. The minimisation method changed from 
steepest descent to conjugate gradient upon reaching half of the maximum number of 
minimisation cycles. After minimisation, the solvated system was heated up to 300 K 
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within 100 ps. The system temperature was regulated by Langevin dynamics with the 
collision frequency of 2.0 ps-1. Besides, the SHAKE algorithm was applied to constrain 
bonds involving hydrogen (Ryckaert et al., 1977). The solvated system was maintained 
at constant volume. Next, the solvated system was equilibrated for 900 ps to relax the 
water box before running 10 ns of production. Both equilibration stage and production 
stage were simulated at constant pressure, controlled by Berendsen at constant 
temperature to mimic laboratory conditions. The MD simulation was performed under 
periodic boundary condition with Particle Mesh Ewald (PME) cutoff at 8.0 Å. The 
time step in simulation was 2 fs. The system equilibrium was monitored in terms of 
energy, temperature, pressure, volume, density and RMSD. A MD representative 
structure was extracted from the equilibrated trajectory (10th ns) via clustering using 
MMTSB toolset (Michael Feig et al., 2004). All protein structure visualisations were 
generated using PyMOL (Delano, 2002).  
 
2.3.4 Free Energy Calculations and Per-Residue Decomposition  
The binding free energy of HSP16.3-bisANS complex was calculated using 
MM-GBSA/PBSA. The calculations were performed using snapshots extracted at 10 
ps intervals from single MD trajectory of complex at the 10th ns MD simulation 
trajectory. In MM-GBSA, the polar solvation free energy was approximated by 
applying the modified GBOBC (II) model (Onufriev et al., 2004) (igb=5) using mbondi2 
radii set. The Linear Combination of Pairwise Overlaps (LCPO) method (Weiser et al., 
1999) was used for determining the non-polar solvation free energy. The surface 
tension parameter used was 0.0072 kcal/mol/A2. In MM-PBSA, the polar solvation 
free energy was calculated by solving the PB equation. The non-polar solvation free 
energy was calculated by classical model (inp=1) using surface tension parameter that 
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was set at 0.005 kcal/mol/A2. The radii from topology files (radiopt=0) were used for 
PB calculation and its non-polar calculations. By using the same set of radii for both 
MM-GBSA/PBSA approach, it ensures consistency between the calculations for 
comparison purpose. The interior and exterior dielectric constant was set to 1.0 and 
80.0 in both MM-GBSA/PBSA calculations. Due to surface hydrophobicity of 
HSP16.3, lower interior dielectric constant was employed in this study. It has been 
reported that low solute dielectric constant (Ԑin = 1) is generally applicable for 
hydrophobic environment whereas high solute dielectric constant (Ԑin > 1) is suitable 
for charged environment (Hou et al., 2011a). The interaction energy between HSP16.3 
and bisANS was also studied by decomposing the total binding free energy into its 
individual contributions on a per-residue basis.  
 
2.4 Results 
2.4.1 Sequence Analysis of HSP16.3 
Secondary structure predictions showed HSP16.3 was overrepresented in beta 
strands (Table 2.1). Based on the consensus prediction, beta strands were found 
distributing among residues 42-46, 50-56, 66-71, 74-80, 90-94, 96-103, 113-117, 121-
127 and 137-141. Besides, the N-terminal (residues 15-23) was predicted to adopt 
helical conformation. The proposed secondary structures of HSP16.3 is consistent with 
protein disordered region prediction results. The protein residues which presumably 
involved in forming secondary structure element were also predicted to fall into 
ordered regions of HSP16.3 (Table 2.2). The results showed that residues 1-7, 56, 79-
84 and 142-144 were disordered regions, as agreed by prediction servers. Therefore, 
these identified regions are likely unstable and do not have regular structures.  
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Table 2.1 Secondary structure prediction by APSSP2 (Raghava, 2002), Jpred4 (Drozdetskiy et al., 2015), SSpro (Cheng, Randall, et 
al., 2005), PORTER (Pollastri & McLysaght, 2005), PredictProtein (Rost et al., 2004) and PSIPRED v3.3 (Buchan et al., 2013; Jones, 
1999). Indicator: H – alpha helix; B – beta strand 
 
HSP16.3 sequence 
1 11 21 31 41 51 
MATTLPVQRH PRSLFPEFSE LFAAFPSFAG LRPTFDTRLM RLEDEMKEGR YEVRAELPGV 
APSSP2 ---------- HHHHHHHHHH HHHHH----- ---------- ---BBB---B BBBBBB---- 
Jpred4 ---------- ------HHHH HH-------- ---------- -BBBBB---B BBBBBBB--- 
SSpro ------H--- ---HHHHHHH HH-------- ---------- -BBBBB---B BBBBBB---- 
PORTER ---------- ----HHHHHH HHH------- ---------- -BBBBB---B BBBBBB---- 
PredictProtein ---------- HHHHHHHHHH HHHH------ ---------- -BBBBB---B BBBBBBB--- 
PSIPRED v3.3 ---------- -----HHHHH HHH------- ---------B BBBBBBB--B BBBBBB---- 
Consensus ---------- ----HHHHHH HHH------- ---------- -BBBBB---B BBBBBB---- 
 
61 71 81 91 101 111 
DPDKDVDIMV RDGQLTIKAE RTEQKDFDGR SEFAYGSFVR TVSLPVGADE DDIKATYDKG 
APSSP2 ----BBBBBB B--BBBBBBB B-------BB BBBBB-BBBB BBB------H HHBBBBB--- 
Jpred4 ----BBBBBB B--BBBBBBB --------BB BBBBBBBBBB BB-------- --BBBBB--- 
SSpro -----BBBBB ---BBBBBBB ---------- BBBB---BBB BBB------H HHBBBBB--- 
PORTER ------BBBB B--BBBBBBB ---------- -----BBBBB BBB------H HH-BBBB--- 
PredictProtein ---BBBBBBB B--BBBBBBB ---------- -----BBBBB BBB------- -BBBBBBB-- 
PSIPRED v3.3 -----BBBBB B--BBBBBBB BBBBB----B BBBBBBBBBB BBB------- ---BBBB--- 
Consensus -----BBBBB B--BBBBBBB ---------B BBBB-BBBBB BBB------- --BBBBB--- 
 121 131 141    
 ILTVSVAVSE GKPTEKHIQI RSTN    
APSSP2 BBBBBBB--- -----BBBBB B---    
Jpred4 BBBBBBBB-- ------BBBB B---   
SSpro BBBBBB---- ------BBBB B---   
PORTER BBBBBB---- -----BBBBB BB--    
PredictProtein BBBBBBB--- -----BBBBB B---    
PSIPRED v3.3 BBBBBBB--- ------BBBB BB--    
Consensus BBBBBBB--- ------BBBB B---    
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Table 2.2 Prediction of protein disordered regions in HSP16.3 by DISpro (Cheng, Sweredoski, et al., 2005), IUPred (Dosztányi et al., 
2005), Meta-Disorder (Kozlowski & Bujnicki, 2012), PONDR (Li et al., 1999; Romero et al., 2001), PrDOS (Ishida & Kinoshita, 2007) 
and RONN v3.2 (Yang et al., 2005).  
 
 1 11 21 31 41 51 
HSP16.3 sequence MATTLPVQRH PRSLFPEFSE LFAAFPSFAG LRPTFDTRLM RLEDEMKEGR YEVRAELPGV 
DISpro DDDDDDDDDO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
IUPred DDDOODOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO DDDDDDOOOO 
Meta-Disorder DDDDDDDDDD DDDDDDDODD DDDDDDDDDD DDDDDDDDDD DDDDDDDDDD OOOOODDDDD 
PONDR DDDDDDDOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO ODDDDDDDDD DDDDDDDDDD 
PrDOS DDDDDDDDDD DDOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
RONN v3.2 DDDDDDOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOODDDDDDD DDDDDDDDOO 
Consensus DDDDDDDOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOODOOOO 
 61 71 81 91 101 111 
 DPDKDVDIMV RDGQLTIKAE RTEQKDFDGR SEFAYGSFVR TVSLPVGADE DDIKATYDKG 
DISpro OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
IUPred OOOOOOOOOO DDOOOOOODD DDOOOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
Meta-Disorder DDDDDOOOOO ODDDDDDDDD DDDDDDDDDD DDDDDDOOOO ODDDDDDDDD DDDDDOOODO 
PONDR DDDDDDDDDD DDDDDDDDDD DDDDOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
PrDOS OOOOOOOOOO OOOOOOOOOO OODDDDDDDD DOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
RONN v3.2 OOOOOOOOOO OOOODDDDDD DDDDDDOOOO OOOOOOOOOO OOODDDDDDD DDDDDDDDOO 
Consensus OOOOOOOOOO OOOOOOOODD DDDDOOOOOO OOOOOOOOOO OOOOOOOOOO OOOOOOOOOO 
 121 131 141    
 ILTVSVAVSE GKPTEKHIQI RSTNoooooo    
DISpro OOOOOOOOOO OOOOOOOOOO OODDoooooo    
IUPred OOOOOOOOOO OODDDDDDDD DDDDoooooo    
Meta-Disorder OOOODDDDDD DDDDDDDDDD DDDDoooooo   
PONDR OOOOOOOOOO OOOODOOOOO OOODoooooo   
PrDOS OOOOOOOOOO OOOOODDDDD DDDDoooooo   
RONN v3.2 OOOOOOOOOO OOOOOOOOOO ODDDoooooo   
Consensus OOOOOOOOOO OOOOOOOOOO ODDDoooooo    
Indicator: D – disordered region; O – ordered region
